Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study

BACKGROUND: In Europe, administration of an inhaled corticosteroid (ICS) combined with a long-acting β2 agonist is approved in chronic obstructive pulmonary disease (COPD) patients with a pre-bronchodilator FEV(1) < 60% predicted normal, a history of repeated exacerbations, and who have significa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Roche, Nicolas, Pribil, Céline, Van Ganse, Eric, Serrier, Philippe, Housset, Bruno, Poirier, Déborah, Texier, Nathalie, Schück, Stéphane, Boucot, Isabelle
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3997842/
https://ncbi.nlm.nih.gov/pubmed/24694050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-56
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller